NEW YORK (AP) — Swiss drugmaker Roche said Monday the Food and Drug Administration approved a test it developed that detects the hepatitis B virus in blood.
Roche said the test can detect an antigen that indicates acute or recent hepatitis B infection. The test is designed to run on Roche's cobas diagnostic system.
Hepatitis B is spread through blood and bodily fluids. Symptoms can include fatigue, fever, muscle and joint aches, nausea and vomiting, and jaundice. People who develop the chronic form of the disease face higher risks of liver cancer and cirrhosis.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
